Authors
Latest:
Analyzing the Impact of Different Value-Based Insurance Design ProgramsTotal 1-year healthcare costs were not significantly reduced by 2 value-based insurance design programs for diabetic patients, although education appeared to improve quality of care.
Latest:
Postsurgical Pain ControlData from large survey reports suggest that more than 80% of Americans who undergo surgery experience some level of postsurgical pain.
Latest:
Zooming Through the Pandemic: NSU Virtual AMCP Student ChapterThere are many benefits to adopting and integrating new technological methods for hosting pharmacy organization events.
Latest:
Value Based Contracts for Specialty PharmacyIn an era of high-priced drugs, health care stakeholders continue to explore alternative pricing models that focus on the concept of value-based drug purchasing models.
Latest:
Oncology Therapy Choices Under Greater Scrutiny From PayersThe cost of oncology treatment is high and rising in the United States.
Latest:
Top 200 Drugs of 2010This close look at the top 200 drugs of 2010 by sales and prescriptions dispensed reveals the story of a pharmaceutical market in flux.
Latest:
Antidepressant Discontinuation: What the Tertiary Databases and Package Insert Tells YouDiscontinuation of antidepressants should take place gradually, as abrupt stoppage or marked reduction in the dosage of an antidepressant is frequently associated with adverse effects (AEs), such as withdrawal symptoms.
Latest:
Detecting Signs of Opioid Abuse and Treating the AddictionKnowing the warning signs and establishing trust are crucial to identifying and treating the opioid abuser.
Latest:
Medication Reconciliation: 2013 and BeyondThe entrepreneurial pharmacist has the responsibility of creating the value proposition for providing medication reconciliation.
Latest:
Statement by Ralph G. Neas, President and CEO, GPhA, Regarding 21st Century CuresGPhA commends House Energy and Commerce Committee Chairman Fred Upton, Ranking Member Frank Pallone, Rep. Diana DeGette, Health Subcommittee Chair Joe Pitts, and Health Subcommittee Ranking Member Gene Green for their bipartisan leadership around fostering the development of new cures.
Latest:
A Diabetes Success StoryOne of the most enduring lessons from my training in the care of geriatric patients is the following maxim: “Treat every new symptom like a (possible) drug adverse effect until proven otherwise.”
Latest:
A Tribute to Oncology NursesOncology nurses help improve patient outcomes through their dedication and expertise.
Latest:
Taking Medication in Diabetes Self-Management: Issues and Recommendations for Reducing BarriersThis paper considers opportunities and barriers relating to medication taking and self-management by people with diabetes and related conditions as discussed during an invitational symposium.
Latest:
Depression and Breast-Feeding: Medication UseKnowledgeable pharmacists can positively influence mothers who are depressed as well as women who want to breast-feed but do not because of medication use.
Latest:
Rethinking Pharmacy Employee EngagementWhile often overlooked, employee engagement is a key element in determining whether a hospital, health system, or pharmacy service can effectively meet its patient access, patient quality, and organizational financial demands.
Latest:
Laser Focused in Drug UsageA model of formulary decision making that evaluates medications based on usage could have significant implications for providers, consumers, and manufacturers.
Latest:
Decongestants and Hypertension: Dangerous TogetherNearly 33% of adults in the United States have the typically symptomless disease known as hypertension.
Latest:
Trends Associated with Implementing and Lifting a Pregabalin Step Therapy PolicyThis study examined the impact of a pregabalin step therapy policy on utilization and medical costs in Humana’s Medicare and commercial plans.
Latest:
Continuous Glucose Monitoring: An Opportunity to Understand and Individualize Diabetes ManagementFor patients with diabetes, continuous glucose monitoring offers the opportunity to lessen the burden of traditional finger sticks.
Latest:
Comparative Treatment Patterns Among Psoriasis Patients Using Adalimumab, Etanercept, or UstekinumabThis retrospective study compared the treatment patterns of ustekinumab with recommended maintenance administration every 12 weeks, with adalimumab and etanercept, administered weekly or every other week, for the treatment of plaque psoriasis.
Latest:
Comparative Effectiveness of Fidaxomicin for Treatment of Clostridium Difficile InfectionOur analysis models the clinical and economic value of fidaxomicin for the treatment of Clostridium difficile infection compared with metronidazole and vancomycin.
Latest:
Shionogi Pharma's KapvayThe FDA approved Kapvay (clonidine hydrochloride extended -release) as a monotherapy and adjunctive therapy for the treatment of attention- deficit/hyperactivity disorder in children and adolescents aged 6 to 17 years.
